$5.18
1.89% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US64157F1030
Symbol
NVRO
Sector

Nevro Stock price

$5.18
-3.51 40.39% 1M
-9.36 64.37% 6M
-16.34 75.93% YTD
-15.12 74.48% 1Y
-119.64 95.85% 3Y
-82.03 94.06% 5Y
-20.01 79.44% 10Y
NYSE, Closing price Fri, Sep 06 2024
-0.10 1.89%
ISIN
US64157F1030
Symbol
NVRO
Sector

Key metrics

Market capitalization $193.13m
Enterprise Value $162.10m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.38
P/S ratio (TTM) P/S ratio 0.45
P/B ratio (TTM) P/B ratio 0.70
Revenue growth (TTM) Revenue growth 1.59%
Revenue (TTM) Revenue $426.10m
EBIT (operating result TTM) EBIT $-93.87m
Free Cash Flow (TTM) Free Cash Flow $-70.96m
Cash position $273.69m
EPS (TTM) EPS $-2.12
P/E forward negative
P/S forward 0.48
EV/Sales forward 0.40
Short interest 9.39%
Show more

Is Nevro a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Nevro Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Nevro forecast:

12x Hold
71%
5x Sell
29%

Analyst Opinions

17 Analysts have issued a Nevro forecast:

Hold
71%
Sell
29%

Financial data from Nevro

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
426 426
2% 2%
100%
- Direct Costs 150 150
2% 2%
35%
277 277
1% 1%
65%
- Selling and Administrative Expenses 302 302
3% 3%
71%
- Research and Development Expense 55 55
1% 1%
13%
-80 -80
14% 14%
-19%
- Depreciation and Amortization 13 13
26% 26%
3%
EBIT (Operating Income) EBIT -94 -94
10% 10%
-22%
Net Profit -77 -77
3,125% 3,125%
-18%

In millions USD.

Don't miss a Thing! We will send you all news about Nevro directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nevro Stock News

Neutral
PRNewsWire
10 days ago
REDWOOD CITY, Calif. , Aug. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in a "fireside chat" (question-and-answer) session at the Wells Fargo 2024 Healthcare Conference on Friday, September 6, 202...
Neutral
PRNewsWire
24 days ago
REDWOOD CITY, Calif. , Aug. 14, 2024  /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on August 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 10,199 shares of Nevro's common stock ...
Negative
Seeking Alpha
29 days ago
Nevro Corp.'s shares hit fresh lows after revenue guidance reset, reflecting stagnant growth and substantial losses. The company has seen an eventful decade with huge share price fluctuations, but the situation is quite severe right now. Competitive pressures hurt the topline sales, as the loss rate is very substantial, leaving few opportunities to grow out of this situation here.
More Nevro News

Company Profile

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

Head office United States
CEO Kevin Thornal
Employees 1,215
Founded 2006
Website www.nevro.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today